2nd Quarter - Report

TODD STRATEGY GROUP for BIODESIX, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare treatment of outpatient reimbursement for laboratory tests. H.R.5800: Ban Surprise Billing Act. S.3404 VALID Act of 2020.

LobbyistCovered position, as disclosed
PAUL EDATTEL Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
DANIEL M TODD Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 5800 (117th), S. 3404 (117th)

Health Issues HCR

COVID-19 Response.

LobbyistCovered position, as disclosed
PAUL EDATTEL —
DANIEL M TODD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.